Table 6.
Drugs that affect gastric health and their mode of action.
| Drug | Action | Association with gastric disease | Reference |
|---|---|---|---|
| Ranitidine, Cimetidine | Acid suppression | Increases the risk of gastric adenocarcinoma | Rodriguez et al., 2006 |
| Omeprazole, Pantoprazole | Proton pump inhibition | Positive association with gastric diseases. | Mărginean et al., 2018 |
| Metformin | Blood sugar control(Diabetes treatment) | Alleviate gastric disease risk by increase the abundance of bacteria that produce short-chain fatty acids (SCFAs) | Forslund et al., 2015 |
| Aspirin | NSAIDS; enhance the secretion of pro-inflammatory cytokines | Positively associated with gastric ulcer | Musumba et al., 2009 |